Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma

Journal of Glaucoma

Volumn 19, Issue 9, 2010, Pages 598-603

  Chen, Philip P ^a   Cady, Robert Samuel ^a   Mudumbai, Raghu C ^a   Ngan, Rose ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

glaucoma; progression; rate; visual field

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TRABECULECTOMY; VISUAL FIELD;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 78650493562     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181d12e1e     Document Type: Article

References (25)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262-267.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487-497.
3. AGIS group. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology. 1998;105:1146-1164.
4. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
5. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
6. Heijl A, Leske C, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268-1279. (Pubitemid 36105431)
7. Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology. 2000;107:1688-1692.
8. Chen PP. Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology. 2002; 109:2093-2099. (Pubitemid 35222567)
9. Anderson DR. Automated Static Perimetry. St. Louis: CV Mosby; 1992:91-137.
10. Sharma AK, Goldberg I, Graham SL, et al. Comparison of the Humphrey Swedish Interactive Thresholding Algorithm (SITA) and full threshold strategies. J Glaucoma. 2000;9:20-27. (Pubitemid 32440546)
11. Advanced glaucoma intervention study. 2. Visual field test scoring and reliability. The advanced glaucoma intervention study investigators. Ophthalmology. 1994;101:1445-1455.
12. Spaeth GL. Defining glaucoma, defining disease: The 1998 Dohlman lecture. Int Ophthalmol Clin. 1999;39:1-14. Winter.
13. Caprioli J. The importance of rates in glaucoma. Am J Ophthalmol. 2008;145:191-192.
14. Rasker M, van den Enden A, Bakker D, et al. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000; 118:481-488. (Pubitemid 30203142)
15. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428. (Pubitemid 26177317)
16. O'Brien C, Schwartz B, Takamoto T, et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 1991;111:491-500.
17. CNTGS Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108:247-253. (Pubitemid 32115951)
18. Shigeeda T, Tomidokoro A, Araie M, et al. Long-term follow-up of visual field progression after trabeculectomy in progressive normal-tension glaucoma. Ophthalmology. 2002; 109:766-770. (Pubitemid 34270137)
19. Broman AT, Quigley HA, West SK, et al. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci. 2008;49:66-76.
20. Nouri-Mahdavi K, Hoffman D, Gaasterland D, et al. Prediction of visual field progression in glaucoma. Invest Ophthalmol Vis Sci. 2004;45:4346-4351. (Pubitemid 39564659)
21. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343-353.
22. Anderson DR, Drance SM, Schulzer M, Collaborative normaltension glaucoma study group. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol. 2003;136:820-829. (Pubitemid 37330024)
23. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134-142. (Pubitemid 32441322)
24. Nakagami T, Yamazaki Y, Hayamizu F. Prognostic factors for progression of visual field damage in patients with normaltension glaucoma. Jpn J Ophthalmol. 2006;50:38-43. (Pubitemid 43201032)
25. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al, Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Ophthalmology. 2004;111:1627-1635. (Pubitemid 39179673)